ChromaCode Leadership

Bringing data driven medicine to the masses.I wear three hats. I am the Founder, Chief Technology Officer, and member of the Board of Directors of ChromaCode, a cutting-edge software and reagent technology company that uses digital signal processing to dramatically improve clinical molecular analysis. In my academic life, I am part-time faculty at Caltech and USC, where I work on novel medical imaging hardware, digital signal processing, nano-scale electronics, low-power circuits for implantable sensor systems.Finally, I am a venture partner at ND Capital investing in the nexus of data and physical/life sciences.

Greg has over 20 years of management experience in the molecular diagnostics and nucleic acids research fields. He spent 9 years at Luminex, when the company grew revenues from $30 million to over $200 million. He held multiple roles including VP of Sales and Marketing, where he was responsible for global commercial operations, and VP/GM of Biosciences, where was responsible for developing novel instrument and assay products for gene expression, microRNA, newborn screening and Alzheimer's disease. Prior to Luminex, Greg served in various commercial leadership roles at Nanogen, Chiron Diagnostics and Bio-Rad. He has a bachelors degree in molecular, cellular and developmental biology from the University of Colorado and dual masters degrees in business and healthcare administration from the University of Minnesota.

Bringing data driven medicine to the masses.I wear three hats. I am the Founder, Chief Technology Officer, and member of the Board of Directors of ChromaCode, a cutting-edge software and reagent technology company that uses digital signal processing to dramatically improve clinical molecular analysis. In my academic life, I am part-time faculty at Caltech and USC, where I work on novel medical imaging hardware, digital signal processing, nano-scale electronics, low-power circuits for implantable sensor systems.Finally, I am a venture partner at ND Capital investing in the nexus of data and physical/life sciences.

Greg has over 20 years of management experience in the molecular diagnostics and nucleic acids research fields. He spent 9 years at Luminex, when the company grew revenues from $30 million to over $200 million. He held multiple roles including VP of Sales and Marketing, where he was responsible for global commercial operations, and VP/GM of Biosciences, where was responsible for developing novel instrument and assay products for gene expression, microRNA, newborn screening and Alzheimer's disease. Prior to Luminex, Greg served in various commercial leadership roles at Nanogen, Chiron Diagnostics and Bio-Rad. He has a bachelors degree in molecular, cellular and developmental biology from the University of Colorado and dual masters degrees in business and healthcare administration from the University of Minnesota.

Bringing data driven medicine to the masses.I wear three hats. I am the Founder, Chief Technology Officer, and member of the Board of Directors of ChromaCode, a cutting-edge software and reagent technology company that uses digital signal processing to dramatically improve clinical molecular analysis. In my academic life, I am part-time faculty at Caltech and USC, where I work on novel medical imaging hardware, digital signal processing, nano-scale electronics, low-power circuits for implantable sensor systems.Finally, I am a venture partner at ND Capital investing in the nexus of data and physical/life sciences.

Greg has over 20 years of management experience in the molecular diagnostics and nucleic acids research fields. He spent 9 years at Luminex, when the company grew revenues from $30 million to over $200 million. He held multiple roles including VP of Sales and Marketing, where he was responsible for global commercial operations, and VP/GM of Biosciences, where was responsible for developing novel instrument and assay products for gene expression, microRNA, newborn screening and Alzheimer's disease. Prior to Luminex, Greg served in various commercial leadership roles at Nanogen, Chiron Diagnostics and Bio-Rad. He has a bachelors degree in molecular, cellular and developmental biology from the University of Colorado and dual masters degrees in business and healthcare administration from the University of Minnesota.